ARCHIVES

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

November 22, 2006

Editorial: Ambiance Through Exclusion

May 20, 1994

Animas As Early Warning “Sentinels” Part Of DCE Study

July 31, 1987

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

Biology Societies Endorse Cloning Prohibition Act.

February 1, 2002